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Abstract
Background: Previous studies have shown associations between obsessive-compulsive disorder (OCD) and hypothalamic-
pituitary-adrenal axis activity (HPA). We aimed to investigate the association between obsessive-compulsive (OC) symptoms
and HPA axis functionality in a non-clinical sample and to explore whether there are sex differences in this relationship.
Methods: One hundred eighty-three healthy individuals without any psychiatric diagnosis (80 men, 103 women; mean age
41.3 ± 17.9 years) were recruited from the general population. The Obsessive-Compulsive Inventory Revised (OCI-R) was used
to assess OC symptoms. State-trait anxiety, perceived stress, and stressful life events were also assessed. Saliva cortisol levels
were determined at 6 time points (awakening, 30 and 60 min post-awakening, 10:00 a.m., 23:00 p.m. and 10:00 a.m. the
following day of 0.25mg dexamethasone intake [that occurred at 23:00 p.m.]). Three HPA axis measures were calculated:
cortisol awakening response (CAR), cortisol diurnal slope, and cortisol suppression ratio after dexamethasone (DSTR). Multiple
linear regression analyses were used to explore the association between OC symptoms and HPA axis measures while
adjusting for covariates. Our main analyses were focused on OCI-R total score, but we also explored associations with specific
OC symptom dimensions.
Results: No significant differences were observed between males and females in OC symptoms, anxiety measures, stress, or
cortisol measures. In the multiple linear regression analyses between overall OC symptoms and HPA axis measures, a female
sex by OC symptoms significant interaction (standardized beta = − 0.322; p = 0.023) for the CAR (but not cortisol diurnal
slope nor DSTR) was found. Regarding specific symptom dimensions, two other sex interactions were found: a blunted
CAR was associated with obsessing symptoms in women, whereas a more flattened diurnal cortisol slope was associated
with ordering symptoms in men.
Conclusions: There are sex differences in the association between OC symptoms and HPA axis measures in healthy
individuals.
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Introduction
Obsessive-compulsive disorder (OCD) is a common
chronic long-lasting psychiatric disorder, with a preva-
lence of 2.3% that interferes with all aspects of life of the
individual [1]. OCD is characterized by the presence of
obsessions, repetitive disturbing and uncontrollable
thoughts that persist despite the patient’s efforts to sup-
press or ignore them, and compulsions and repetitive and
ritualized behaviors or mental acts aimed at neutralizing
obsession-induced anxiety [2]. Obsessive-compulsive
(OC) symptoms are not exclusive of OCD. They are
prevalent in non-clinical samples, with clinically relevant
symptoms in about 21.7% of the general population [3].
The vulnerability to compulsive activity can be predicted
by a spectrum of neuropsychological mechanisms such as
impaired motor inhibition, cognitive inflexibility and an
imbalance in goal-directed vs habit learning [4]. A series
of cortico-striato-thalamo-cortical circuits that are associ-
ated with these cognitive changes are believed to underpin
the expression of compulsive behaviors [4].
The hypothalamic-pituitary-adrenal (HPA) axis, the
major stress response system of the body, is known to
be involved in the susceptibility to develop psychiatric
disorders and physical conditions such as infectious dis-
eases, cardiovascular problems, autoimmune processes,
chronic fatigue syndrome, and rheumatoid arthritis [5].
Stressful life events and dysregulations of the HPA axis
are thought to play a role in the pathogenesis of the
OCD [6, 7] and other anxiety disorders [8]. The first
studies to explore the relationship between HPA axis
functionality and OCD measured HPA hormones in
cerebrospinal fluid (CSF) and blood. For instance, ele-
vated values of corticotropin releasing hormone (CRH)
in CSF [9], increased nocturnal secretion of adrenocorti-
cotropic hormone (ACTH) [10], and higher basal serum
cortisol values [11, 12] have been described in OCD
patients.
In the last two decades, the study of HPA axis func-
tionality using saliva samples has attracted great interest
[13]. Saliva collection allows cortisol determination at
different moments of the day with a non-invasive pro-
cedure. Therefore, saliva sampling can be used for study-
ing several dynamic tests of the HPA axis, such as the
cortisol awakening response (CAR), the diurnal cortisol
rhythm, or the negative feedback of the HPA axis with
the study of the cortisol suppression by dexamethasone.
We have used this approach to study the role of these
HPA axis measures in patients with OCD, major depres-
sive disorder (MDD) and healthy individuals [6]. A more
flattened diurnal cortisol slope calculated between 10
and 23 h was observed for OCD patients with comorbid
MDD. We also found that trait anxiety was a moderator
of the relationship between OCD and HPA axis mea-
sures, as OCD patients with greater trait anxiety showed
an increased CAR and reduced cortisol suppression after
dexamethasone administration. Saliva sampling also al-
lows the study of the cortisol response to psychosocial
stress. In this line, previous studies exploring the cortisol
response to the Trier Social Stress Test, a social stress
procedure, in patients with OC personality disorder have
revealed an attenuated response in male patients com-
pared to male controls, whereas no significant differ-
ences were found in women [14].
There is a wealth of data describing sex differences in
HPA axis, documented as early as the neonatal period
and at all individual levels of the HPA axis [15]. Evi-
dence on sex differences in the HPA axis response to
stress is conflicting, with some studies showing no dif-
ferences. But the overall picture seems to indicate that
the response to psychological stress in adult men is with
greater increases in cortisol in comparison to women
[5]. However, the study of sex differences in the HPA
axis response is more complex if we consider potential
moderating variables. For instance, the type of the stres-
sor seems to influence the HPA axis response: men show
greater cortisol responses to a mathematical and verbal
challenge whereas women show greater cortisol re-
sponses to a social rejection challenge [16]. Age and gen-
der are also moderators of the HPA response to
psychosocial stress. In a study exploring ACTH and cor-
tisol responses to the TSST in healthy elderly adults,
younger adults, and children, there was no age effect in
the subgroup of women, whereas younger men had
higher ACTH responses compared to older men [17]. In
relation to free salivary cortisol, an enhanced cortisol re-
sponse in elderly men compared to elderly women was
observed, while no gender differences emerged in nei-
ther young adults nor children [17].
The study of potential sex differences regarding HPA
axis activity in the field of OCD has been an underre-
searched area. This approach is important because sex
plays a role in the clinical expression of the illness:
women show, when compared to men, more contamin-
ation/cleaning symptoms [18–21], more aggressive ob-
sessions and hoarding symptoms [20], more somatic
obsessions [19], less sexual/religious obsessions [18, 22],
and less checking and repeating compulsions [22]. Con-
versely, other studies have failed to find sex differences
in OCD symptom dimensions [23]. However, in that
study correlations between the distinct types of OCD
symptom dimensions were stronger in men compared to
women. It is plausible that sex differences in HPA axis
activity could contribute to the different clinical expres-
sion of obsessive-compulsive symptoms between men
and women. However, previous studies studying HPA
axis measures in OCD [6, 9–12] did not specifically ex-
plore whether there were sex differences on these
relationships.
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The main aim of our study was to explore the role of
the HPA axis in the clinical expression of obsessive-
compulsive (OC) symptoms in a non-clinical sample. To
our knowledge, this issue has not been studied up to
date. As there are sex differences in the presentation of
OC symptoms and HPA axis activity, we also aimed to




One hundred eighty-three healthy individuals (80 men,
103 women; mean age 41.3 ± 17.9 years) were recruited
from the general population by advertisements in the
community. Recruitment was conducted in two prov-
inces (Barcelona, Tarragona) from Catalonia (Spain) by
clinical researchers from the Department of Psychiatry
at Bellvitge University Hospital (Hospitalet de Llobregat,
Barcelona) and from the Hospital Universitari Institut
Pere Mata (Reus, Tarragona). All participants had no
past or current history of psychiatric disorders (includ-
ing OCD) and a score below 7 on the 28-item Spanish
adaptation of the Goldberg General Health Question-
naire (GHQ-28) [24]. Exclusion criteria were age less
than 18 years, a diagnosis of a psychiatric disorder in-
cluding substance abuse or dependence (except nico-
tine), mental retardation, neurological disorders, severe
medical conditions, pregnancy, or puerperium and cor-
ticosteroid treatment in the previous 3 months. Two
women were receiving contraceptive pills. The research
protocol was approved by the Ethics Committees of Bell-
vitge University Hospital and Hospital Universitari Sant
Joan, and all participants provided written informed con-
sent after having received a full explanation of the study.
Clinical assessment
From a semi-structured interview, a sort of sociodemo-
graphic and clinical variables and substance use were
assessed. In order to calculate the body mass index,
weight and height were measured in all participants,
using the formula (kg)/height(m2).
The assessment of the OC symptoms was performed
using the Obsessive-Compulsive Inventory Revised
(OCI-R). The OCI-R consists of a self-reported test of
18 items divided on six subscales: washing, checking, or-
dering, obsessing, hoarding, and neutralizing. Each item
is scored on a 5-point scale (0–4 points), and the total
score is the sum of the scores on all items. It also pro-
vides scores for the six subscales [25]. The OCI-R has
proved its validity in both clinical [25, 26] and non-
clinical samples [27] and has been validated to Spanish
[28]. A cut-off score of 21 has been recommended, with
scores at or above this level indicating the likely pres-
ence of OCD [25].
Several psychometric scales were administered to as-
sess anxiety and stress measures of all participants.
Current and trait anxiety were measured with the State-
Trait Anxiety Inventory [29]. Stressful life events that
occurred in the 6 previous months were assessed with
the Holmes-Rahe Social Readjustament Scale [30], that
has been also used in Spanish populations [31]. Per-
ceived stress during the previous month was assessed
with the 14-item Perceived Stress Scale (PSS) [32].
Collection of saliva samples
Saliva samples were obtained using Salivette (Sarstedt
AG & Co., Nümbrecht, Germany) containers. Partici-
pants were instructed to collect repeated saliva samples
at home during a regular day and to avoid intense phys-
ical activity and stressful situations. Fifteen minutes be-
fore sample collection, participants were told not to eat,
drink, smoke, or brush their teeth.
Saliva samples were obtained at awakening (T1), 30
(T2) and 60 (T3) min after awakening, at 10 a.m. (T4)
and at 11 p.m. (T5) on the same day. Participants were
told to take a very low dose of dexamethasone (0.25 mg)
at 11 p.m. just after T5 sampling. Another saliva sample
was obtained the day after at 10 a.m. (T6).
The samples were kept refrigerated and returned per-
sonally by each participant. After receipt, the Salivettes
were stored at − 20 °C and sent to the BioBank from the
Institut de Investigació Sanitaria Pere Virgili (IISPV) for
centrifugation (3000 rpm for 5 min) and aliquotation,
then frozen at − 20 °C until analysis.
Cortisol measurements
An enzyme-linked immunosorbent assay (ELISA) was
performed to determine the cortisol levels in the saliva
samples (IBL International, Hamburg, Germany). The
intra-assay and inter-assay coefficients of variation were
under 8%. The sensitivity of the assay was 0.08 nmol/L.
To assess the HPA axis function, three dynamic tests
were used: the Cortisol Awakening Response (CAR), the
slope between morning and evening cortisol, and the
Dexamethasone Suppression Test Ratio (DSTR) with
very low doses of dexamethasone (0.25 mg).
The CAR is a physiological process, consisting in the
increase of cortisol levels as a response to awakening in
the morning [33]. It combines features of a reactivity
index (response to awakening) with aspects tied to circa-
dian regulation and it has been related to a wide range
of psychosocial, physical, and mental health parameters
[13]. The CAR was calculated, as suggested by Pruessner
and colleagues, using the area under the curve with re-
spect to the increase [34]. The calculation included the
sampling points of T1-T3 samples.
The diurnal cortisol slope is defined as the rate of de-
cline in cortisol levels during the day, from morning to
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evening. It was calculated using the T4 and the T5 sam-
ples. Previous studies have calculated the diurnal cortisol
slope using both awakening to bedtime or fixed time
points (morning to evening), and the implications of this
choice has received little attention [35]. In a previous
study by our group, we detected significant differences
between OCD patients with or without major depression
in a fixed time points diurnal cortisol slope (calculated
between 10 a.m. and 11 p.m.) but not in the awakening
to evening diurnal cortisol slope [6]. Some authors have
suggested that the CAR is influenced by different bio-
logical mechanisms than the rest of the diurnal cortisol
rhythm [36]. For this reason, in this study, we have de-
cided to use the diurnal cortisol slope using fixed time
points that do not include the awakening response (be-
tween 10 a.m. and 11 p.m.).
The DSTR reflects the cortisol suppression ratio to
dexamethasone, a glucocorticoid receptor agonist and
provides information about negative feedback of the
HPA axis. Thus, a lack of suppression after dexametha-
sone administration is considered a measure of gluco-
corticoid resistance. The DSTR was defined as the ratio
of cortisol between T4 and T6 samples (equivalent to
the ratio between cortisol at 10 am of two consecutive
days: before and after dexamethasone administration).
Higher ratios were indicative of greater suppression after
dexamethasone administration.
Statistical analysis
Data processing was performed using SPSS 23.0 (SPSS,
IBM, USA). Normal distribution for all variables was ex-
plored using histograms and normality tests (Kolmogorov-
Smirnov). In order to test for deviations from normality,
the distribution of all continuous variables was explored.
Measures with a skewed distribution were log transformed
(ln) before its use in parametric tests (e.g., T test, Pearson
correlations) or in linear regression analyses when used as
dependent variables. This was the case for OCI-R and
Holmes-Rahe Social Readjustment scales. However, for
cortisol values, we opted for a power transformation
(X’ = (X0.26 − 1)/0.26) to normalize the data, as pro-
posed by Miller and Plessow [37]. The diurnal cortisol slope
was calculated with and without transformed cortisol con-
centrations. However, when parametric tests and multivari-
ate analyses were performed, slopes were calculated using
transformed cortisol values. To calculate the DSTR,
untransformed cortisol values were used, performing the
power transformation after calculating the ratio [38].
T tests were used to compare continuous data between
men and women. Pearson correlations were used to explore
the relationship between continuous variables. Significance
was set at p < 0.05 (bilateral).
To explore the relationship between the status of the
HPA axis, the OC symptoms, and the psychometric scales,
we conducted multiple regression analyses, considering
the HPA axis measures as the dependent variable in each
case. The following independent variables were entered in
each model with the enter procedure: female gender, age,
BMI, smoking, OCI-R scores, Holmes-Rahe Social
Readjustament Scale stress score, STAI-trait score, and
STAI-state anxiety score. The decision for including these
variables was based on the fact that they are known moder-
ators of HPA axis activity [5, 6, 13, 39]. As PSS showed a
high correlation with STAI anxiety subscales, we opted for
not including this variable in the multiple linear regression
analyses. Potential sex by OCI-R interactions were tested
with a forward selection procedure. Therefore, only signifi-
cant interactions were included in the final equations.
First, we performed three separate multiple regression
analysis using, in each one, a different HPA axis measure
(CAR, diurnal cortisol slope, and DSTR) as the dependent
variable. In these models, the OC symptoms, as the total
score of the OCI-R, together with stressful life events and
anxiety measures, were considered the independent
variables.
We also performed additional multiple regression ana-
lyses as an exploratory approach considering different
subscales of the OCI-R (checking, hoarding, neutralizing,
obsessing, ordering, and washing) in relation to each HPA
axis measure. In these multiple linear regression analyses,
one equation was performed for each OCI-R subscore that
was included in the model as an independent variable,
along with the same covariates as described before. Poten-
tial sex by OCI-R subscores interactions were also tested.
As only two women were receiving oral contraceptive
pills, we did not control for this treatment in multivari-
ate analyses. However, we repeated the main analyses
after excluding these two participants to be sure that the
results did not change.
Sample size calculation was performed with G power
3.1.9.2. (Franz Faul, Universität Kiel, Germany). With an
alpha error of 0.05 and a beta error of 0.20 (statistical
power of 80%), considering an effect size (f2) of 0.1 (small
to medium), the required sample size was determined to
be 172 for testing the main hypothesis with multiple linear
regression analyses that included 10 predictors.
Results
Characteristics of the sample
Demographic and clinical characteristics of the sample
are shown in Table 1. Significant sex differences were
found in BMI, as men had higher BMI than women. No
significant sex differences were found regarding age,
OCI-R total score and the OCI-R subscales and the
different psychometric tests evaluated. There were no
sex differences in cortisol concentrations at the different
sampling points or the three derived HPA axis measures
(Table 2).
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Age (years) 41.4 (18.4) 41.3 (17.6) 0.969
Education (years) 12.8 (3.7) 13.5 (3.8) 0.207
BMI (kg/m2) 26.0 (4.6) 24.0 (4.7) 0.006
Smokers, n (%) 19 (23.8) 16 (15.5) 0.161
Tobacco consumption (cig/d), all participants 3.3 (8.1) 1.4 (4.2) 0.058
Tobacco consumption (cig/d), only smokers 14.2 (11.4) 9.3 (6.6) 0.144
OCI-R
OCI-R total score 9.8 (8.8) 9.7 (8.9) 0.895
OCI-R hoarding score 2.4 (2.2) 2.7 (2.6) 0.823
OCI-R checking score 1.6 (1.8) 1.4 (2.1) 0.103
OCI-R ordering score 3.0 (2.5) 3.0 (2.1) 0.547
OCI-R neutralizing score 0.7 (1.5) 0.6 (1.2) 0.616
OCI-R washing score 0.6 (1.4) 0.7 (1.3) 0.254
OCI-R obsessing score 1.5 (2.2) 1.4 (1.9) 0.972
OCI-R ≥ 21, n (%) 10 (12.5) 12 (11.7) 0.861
STAI
STAI-Trait Anxiety subscore 13.0 (8.0) 14.9 (8.7) 0.131
STAI-State Anxiety subscore 11.7 (7.9) 10.9 (6.7) 0.462
Perceived stress scale 17.0 (7.2) 17.7 (7.5) 0.523
Holmes-Rahe Social Readjustment Scale
Number of stressful life events 2.8 (2.6) 3.0 (2.6) 0.572
Stress Score 82.3 (8.8) 90.1 (80.3) 0.356
Abbreviations: BMI body mass index, cig/d cigarettes per day, OCI-R Obsessive-Compulsive Inventory—Revised, STAI State-Trait Anxiety Inventory. Quantitative
variables are presented as mean and standard deviation (SD).






Awakening cortisol (T1), nmol/L 16.0 (11.7) 17.2 (9.0) 0.256
30-min post-awakening cortisol (T2), nmol/L 25.0 (12.6) 24.6 (14.1) 0.499
60-min post-awakening cortisol (T3), nmol/L 19.9 (12.5) 21.3 (12.6) 0.559
10 a.m. cortisol (T4), nmol/L 13.4 (12.2) 12.1 (8.3) 0.780
11 p.m. cortisol (T5), nmol/L 3.7 (5.6) 3.1 (2.3) 0.965
10 a.m. post-dexamethasone cortisol (T6), nmol/L 7.7 (5.6) 3.1 (2.3) 0.229
CAR† 35.8 (59.8) 26.0 (61.6) 0.295
Diurnal cortisol slope‡ − 0.95 (0.69) − 1.08 (0.71) 0.393
DSTR§ 4.7 (7.1) 10.3 (20.4) 0.086
Abbreviations: CAR cortisol awakening response, DSTR dexamethasone suppression test ratio
All variables presented in mean (SD). For cortisol concentrations (T1-T6), diurnal cortisol slope and DSTR, raw data are shown. P values for these HPA axis
measures are generated with transformed cortisol values (in the transformation of the DSTR, we calculated the ratio with untransformed cortisol values and
performed the power transformation after calculating the ratio)
†CAR was calculated with transformed cortisol values
‡Diurnal cortisol slope was calculated using 10 a.m. and 11 p.m. samples
§DSTR = 10 a.m. cortisol/10 a.m. post-dexamethasone cortisol
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Correlation analyses
We explored the relationship of cortisol measurements
with the OCI-R and the psychometric tests. Taking all data
together, the CAR correlated significantly with stressful life
events (r = 0.17, p = 0.021), but not with perceived stress or
trait/state anxiety. When stratifying by sex (Table 3),
CAR correlated with the number of stressful life
events (r = 0.30; p = 0.010) and Holmes-Rahe stress
score (r = 0.29, p = 0.021) only in males.
No correlation was found between OC symptoms and
HPA axis measures in the whole sample, but, stratifying
by sex, a blunted CAR was associated with ordering symp-
toms (r = − 0.22, p = 0.032) in women, whereas a more
flattened diurnal cortisol slope was associated with
Table 3 Sex-stratified correlation analyses exploring the association between psychometric scales and hypothalamic-pituitary-
adrenal axis measures














Number of SLEs 1 0.835** 0.163 0.109 0.080 0.300** 0.210 − 0.133
HRSRS stress score 0.835** 1 0.073 − 0.001 − 0.059 0.290* 0.225 − 0.147
PSS total score 0.163 0.073 1 0.595** 0.603** 0.133 0.202 − 0.145
STAI-state anxiety 0.109 − 0.001 0.595** 1 0.624** − 0.091 0.012 − 0.066
STAI-trait anxiety 0.080 − 0.059 0.603** 0.624** 1 0.129 0.219 0.164
CAR 0.300** 0.290* 0.133 − 0.091 0.129 1 0.332** − 0.064
Diurnal cortisol slope 0.210 0.225 0.202 0.012 0.219 0.332** 1 0.043
DSTR − 0.133 − 0.147 − 0.145 − 0.066 0.164 − 0.064 0.043 1
OCI-R total score 0.180 −0.031 0.238* 0.235* 0.445** 0.110 0.185 0.019
OCI-R washing 0.242* − 0.012 0.298** 0.310** 0.406** 0.207 0.241* − 0.063
OCI-R checking 0.073 − 0.140 0.352** 0.329** 0.464** 0.118 0.004 0.037
OCI-R ordering 0.162 − 0.022 0.153 0.194 0.352** 0.062 0.135 0.056
OCI-R obsessing 0.070 − 0.023 0.235* 0.246* 0.402** 0.171 0.163 − 0.046
OCI-R hoarding 0.146 0.035 0.060 0.015 0.164 0.151 0.255* − 0.186
OCI-R neutralizing 0.292** 0.045 0.207 0.232* 0.381** 0.105 0.149 − 0.039














Number of SLEs 1 0.832** 0.120 − 0.184 − 0.003 0.091 0.045 − 0.078
HRSRS stress score 0.832** 1 0.248* 0.016 0.254* 0.092 0.080 − 0.013
PSS total score 0.120 0.248* 1 0.495** 0.630** − 0.067 0.051 0.074
STAI-state anxiety − 0.184 0.016 0.495** 1 0.611** 0.013 − 0.058 0.088
STAI-trait anxiety − 0.003 0.254* 0.630** 0.611** 1 − 0.147 − 0.017 0.130
CAR 0.091 0.092 − 0.067 0.013 − 0.147 1 0.381** 0.148
Diurnal cortisol slope 0.045 0.080 0.051 − 0.058 − 0.017 0.381** 1 0.151
DSTR − 0.078 − 0.013 0.074 0.088 0.130 0.148 0.151 1
OCI-R total score 0.128 0.270* 0.354** 0.131 0.470** − 0.176 − 0.013 − 0.036
OCI-R washing 0.066 0.085 0.100 0.019 0.224* 0.019 0.043 0.057
OCI-R checking 0.042 0.163 0.239* − 0.069 0.323** − 0.120 − 0.031 0.046
OCI-R ordering 0.087 0.277** 0.311** 0.185 0.352** − 0.220* − 0.046 − 0.127
OCI-R obsessing − 0.085 0.005 0.455** 0.224* 0.561** − 0.196 0.110 0.095
OCI-R hoarding 0.232* 0.298** 0.168 − 0.014 0.232* 0.001 0.021 − 0.032
OCI-R neutralizing 0.065 0.238* 0.406** 0.145 0.459** − 0.138 0.007 − 0.019
Pearson’s correlation coefficients are shown. Significant results are marked with an asterisk (*p < 0.05; **p < 0.01)
Abbreviations: SLEs stressful life events, HRSRS Holmes-Rahe Social Readjustment Scale, STAI State-Trait Anxiety Inventory, CAR cortisol awakening response, DSTR
dexamethasone suppression test ratio, OCI-R Obsessive-Compulsive Inventory—Revised.
Melia et al. Biology of Sex Differences           (2019) 10:55 Page 6 of 11
hoarding (r = 0.26; p = 0.024) and washing (r = 0.24;
p = 0.033) symptoms in men.
Multiple linear regression analyses
Results from the three different multiple regression ana-
lysis considering OC symptoms (OCI-R total score) as
the main independent variable and HPA axis measure-
ments as dependent variables, are shown in Table 4. We
found a female sex by OC symptoms significant inter-
action (standardized beta = - 0.322; p=0.023), indicating
that the relationship between OC symptoms and the
CAR differs between men and women. This interaction
has been depicted in Fig. 1, as there is a positive associ-
ation between OC symptoms and the CAR in men,
whereas a negative association is found in women. No
associations were found between OCI-R scores and
other HPA axis measures (diurnal cortisol slope, DSTR).
Trait anxiety was associated with an increased DSTR
(Table 3).
When repeating the multiple linear regression analyses
for each OCI-R subscore, a female sex by OC symptoms
from the obsessing dimension was found in the analyses
exploring the effect on the CAR (standardized beta = −
0.252, p = 0.032), which means that women with more
obsessions show a more blunted CAR response. In the
analyses regarding the diurnal cortisol slope, OC symp-
toms from the ordering dimension were associated with
a more flattened diurnal cortisol slope (standardized beta
= 0.365, p = 0.006), and a significant female sex by OC
ordering symptoms significant interaction was also
found (standardized beta = − 0.370, p = 0.019). These re-
sults indicate that men with ordering symptoms show a
more blunted diurnal cortisol slope whereas women
show a more negative slope. There were no significant
associations between OCI-R dimensions nor female sex
by OCI-R dimensions interactions in those equations for
the DSTR.
When repeating the analyses excluding the two
women taking oral contraceptive pills, the results did
not change.
Discussion
Our study suggests that obsessive-compulsive symptoms
in healthy individuals are associated with subtle abnor-
malities in HPA axis measures and this association is
moderated by sex. A blunted CAR was associated with
the severity of both overall OC symptoms and obsessing
symptoms in women. A more flattened diurnal cortisol
slope was associated with ordering symptoms in men.
All these findings were adjusted for stressful life events
and trait and state anxiety, suggesting an independent
effect of OC symptoms on HPA axis activity.
There is little information in the scientific literature
regarding the relationship among OC symptoms and
HPA axis status. In fact, to our knowledge there is only
one study that has explored the differences in CAR or
diurnal cortisol slope in patients with OCD [6]. In that
study from our group, we did not find significant differ-
ences between OCD patients and healthy individuals in
CAR although OCD patients with comorbid major de-
pression had a more flattened cortisol diurnal slope. Few
studies have explored the HPA axis sensitivity of the
negative feedback with the classical DST test (adminis-
tration of 1 mg of dexamethasone and assessing cortisol
suppression in plasma), suggesting that OCD patients
show less suppression to dexamethasone than healthy
controls [40], particularly if they have comorbid major
depression [41, 42]. However, in recent studies from our
group using a very low dose of dexamethasone and
assessing the DSTR in saliva, no differences were found
between OCD and healthy controls nor between OCD
patients with or without comorbid depression [6]. In
that study a positive association between trait anxiety
and DSTR was found, which is in accordance with our
Table 4 Results of the multiple linear regression analyses exploring the relationship between obsessive-compulsive symptoms and
HPA axis measures
CAR Diurnal cortisol slope DSTR
Beta p Beta p Beta p
Female gender 0.115 0.306 − 0.085 0.302 0.070 0.388
Age − 0.316 0.001 − 0.040 0.698 0.146 0.149
BMI 0.029 0.756 − 0.074 0.445 − 0.090 0.346
Smoking (cig/day) 0.054 0.489 0.028 0.726 − 0.020 0.801
OCI-R total score 0.225 0.062 0.060 0.507 − 0.123 0.167
HRSRS stress score 0.023 0.777 0.082 0.348 − 0.027 0.752
STAI-Trait Anxiety 0.037 0.742 0.134 0.251 0.264 0.022
STAI-State Anxiety − 0.071 0.469 − 0.147 0.151 − 0.120 0.234
Female gender × OCI-R interaction − 0.322 0.023
Abbreviations: CAR cortisol awakening response, DSTR dexamethasone suppression test ratio, BMI body mass index, OCI-R Obsessive-Compulsive
Inventory—Revised, HRSRS Holmes-Rahe Social Readjustment Scale, STAI State-Trait Anxiety Inventory
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results in the current study, suggesting that trait anxiety
is more relevant for the DST than OC symptoms.
Although no previous studies have explored whether
there are sex differences in the relationship between OC
symptoms and HPA axis measures in healthy individ-
uals, some studies have explored whether there are sex
differences in the association between neuroticism and
HPA axis indices. In a previous study that included
undergraduated students and that assessed neuroticism
with the NEO five-factor inventory, salivary cortisol at
midday (between 10:30 a.m. and 2:30 p.m.) were posi-
tively associated with neuroticism in men and negatively
in women [43]. In another study that included university
students that were also assessed with the NEO 5-factor
inventory, men had more flattened diurnal cortisol
slopes but not differences in the CAR [44]. These two
studies are in line with our results that suggest more
flattened cortisol slopes in healthy individuals with more
ordering OC symptoms. However, it is difficult to com-
pare our results with the scientific literature because
particular studies focused on OC symptoms are lacking.
Clearly, further studies are needed to replicate our find-
ings. The distinct associations between particular OC
symptom dimensions and HPA axis measures might be
explained by differences in the brain correlates of these
symptom dimensions. As discussed in a recent review
[45], several OCD studies have found that increased se-
verity of aggressive/checking obsessions to be related to
smaller gray matter volume in the temporal lobes, ex-
tending into the amygdala and insula, as well as the left
orbitofrontal cortex (OFC), putamen, and right cerebel-
lum volume. In contrast, findings related to the order-
ing/symmetry dimension are less clear, and have
included both bigger and smaller volume of OFC, as well
as bigger volume of other frontal regions such as the
dorsal anterior cingular cortex and medial frontal cortex
[45]. Other studies have reported reduced hippocampal
volumes in OCD patients with more severe ordering and
checking symptoms [46]. The hippocampus, which ex-
erts negative feedback on the HPA axis via glucocortic-
oid and mineralocorticoid receptors, shows sex
differences in response to stressors, with less remodeling
of hippocampal CA3 dendrites in females after chronic
stress [47]. The hippocampus is also thought to play a
role in the cortisol awakening response, as subjects with
hippocampal damage show a blunted CAR [48]. Thus, it
is plausible that some findings regarding sex differences
on the association between OC symptoms and HPA axis
measures (e.g., blunted CAR and more prominent obses-
sing symptoms in women) could be explained by sex dif-
ferences in neurobiological substrates or brain regions
that are involved both in HPA axis regulation and the
clinical expression of OC symptoms. In line with this hy-
pothesis, in the MRI study by Ress et al. [46] which
assessed the relationship between OC symptom dimen-
sions and hippocampal volumes, greater volume reduc-
tions in the hippocampus were observed in a subset of
OCD patients that reported greater obsessing and check-
ing symptoms. Interestingly, in this study, there was a
significant main effect of sex on global hippocampal
Fig. 1 Scatterplot of the relationship between obsessive-compulsive symptoms and the cortisol awakening response by sex
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volume, which suggests that sex is a moderating variable
in the relationship between OC symptoms and hippo-
campal volumes. If this is the case, it is plausible that
there might also exist sex differences in the relation-
ship between the CAR and obsessing symptoms, be-
cause of the important role of the hippocampus on
both the regulation of the negative feedback of the
HPA axis and the CAR.
Some methodological decisions and limitations of our
study need to be discussed. We aimed to study the rela-
tionship between OC symptoms and HPA axis measures
in a non-clinical sample. This decision limits the
generalizability of the findings to individuals with OCD.
However, it allows to test the association between less
severe OC symptoms and subtle HPA axis abnormalities
that are not influenced by the severity of a clinical diag-
nosis, comorbid conditions (e.g., major depression), or
treatments. This “less biased”’ approach might help to
better explore whether a dysregulation of the HPA axis
is contributing to OC symptoms. We did only assess the
CAR over one day. As dexamethasone was administered
at 11:00 p.m., we dismissed the possibility of collecting
further CAR sampling the next day. Although partici-
pants were instructed to collect the saliva samples at
home at the specific times, the timing of the sampling
was not verified with objective methods (e.g., electronic
monitoring systems). Inaccurate sample timing can bias
CAR estimates [13]. Therefore, it is possible that differ-
ences in the accuracy of sampling times might be driven
by obsessive-compulsive symptoms (e.g., more accurate
sampling timing in people with more obsessive-
compulsive symptoms). As already explained in previous
studies from our group [6, 49], we used a very low dose
of dexamethasone (0.25 mg) because salivary cortisol
presents more profound suppression than does plasma
cortisol and because we aimed to explore the DSTR as a
continuous measure (ratio), and the use of higher dexa-
methasone doses would not have allowed us to detect
subtle alterations in HPA axis regulation. The cross-
sectional design of our study prevents us from inferring
causality in the association between OC symptoms and
HPA axis measures. Some exploratory analyses were not
corrected for multiple testing (e.g., associations between
distinct OC symptom dimensions and different HPA
axis measures) [50]. However, it is important to under-
score that these results on OC symptom dimensions are
exploratory and that they need to be confirmed in fur-
ther confirmatory studies.
Perspectives and significance
Although we did not find sex differences in OC symp-
toms, state/trait anxiety or HPA axis measures in healthy
individuals, we found a different association between
HPA axis activity and OC symptoms in women and
men. In summary, our study suggests that sex is a mod-
erator of the relationship between OC symptoms and
HPA axis functionality, as women with more obsessions
showed a more blunted CAR response. Future studies
need to replicate our findings in clinical populations in-
cluding OCD patients in order to know whether these
sex differences are also present in a more severe pheno-
type. Our study suggests that distinct OC symptom di-
mensions might show different associations with HPA
axis measures, and points out to the possibility that
these differences could be secondary to potential alter-
ations in neural substrates that are involved in the regu-
lation of the HPA axis and the clinical expression of OC
symptoms. Although this is a speculative issue, future re-
search is needed to shed light on this issue. In addition,
psychoneuroendocrinological studies exploring the asso-
ciation between OC or anxiety symptoms with HPA axis
activity need to control for potential sex differences.
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